On Wednesday, October 16th, Veratrak’s Chief Executive Officer, Jason Lacombe, was invited to speak about Veratrak’s role in improving visibility, collaboration and data integrity across the pharmaceutical supply chain during the ‘Blockchain in Action’ session at GIANT Health 2019.
The session was well attended with Jason first providing an overview of blockchain and then sharing practical use cases for the technology – subsequently sparking an interactive discussion.
The audience agreed that the current processes for sharing documentation outside the walls of an organisation are not secure or collaborative, with the majority of information being exchanged over email. A few audience members shared stories of their own organisational impact from using unsecure channels of communication like email.
Key takeaways from the session: Many organisations across the pharmaceutical supply chain are currently sharing batch documentation with their suppliers and partners through unsecure, non-collaborative and inefficient channels, with the majority using email. Using a modern SaaS platform, like Veratrak, and blockchain technology, allows for secure and compliant exchange of information outside the walls of an organisation. Although there is hype around new technologies like blockchain, decision makers need to evaluate the practical and best use-cases for their organisations before jumping in. All attendees mentioned that their organisations have document management tools for internal use, however, most do not have dedicated systems for external document collaboration with suppliers and partners. This has led to inefficiencies in collaboration, a lack of visibility into mission-critical supply chain processes, and potential compromise of confidential data.
Veratrak is committed to solving these challenges. Get in touch to find out how we can improve collaboration, security, and visibility outside the walls of your business.